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ABSTRACT 
BACKGROUND 
There is increasing evidence that Parkinson's 
disease (PD) can cause depression. This 
dimension has not been sufficiently studied 
particularly among Nigerian Africans. Our 
aim was to determine the frequency and severity 
of depression among patients with PD and to 
compare this with their healthy counterparts. 
METHODS 
36 conservative patients with a clinical 
diagnosis of PD had the Beck Depression 
Inventory-Il administered to them. A 
structured questionnaire interview and a 
neurological examination including the Hoehn 
and Yahr stage of illness scale and the motor 
section of the Unified Parkinson's Disease 
Rating Scale were performed. An equal 
number of age and sex matched controls were 
also recruited for the study. 
RESULTS 
Of the 36 PD patients, 83.3% had persistently 
low mood. Based on their Beck Depression 
Inventory score, 25% had mild depression, 18% 
had moderate depression and 16.7% had severe 
depression. Depression was worse with disease 
severity. 
CONCLUSION 
Patients with PD had a higher frequency of 
depression compared to their healthy 
counterparts. A multidisciplinary approach to 
the management of PD that includes 
depression-reducing interventions is required 
for this population of patients. 
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INTRODUCTION 
Depression is the most common non-motor 
symptom of PD [1]. It has been the focus of 
numerous research studies in PD [2-
6].Depression in the context of PD can be 
reactive, caused by the incurable, progressive 
nature of the disease, and therefore can be an 
understandable reaction to disease and its 
consequences [3]. On the other hand, there is a 
widespread and severe disruption of 
monoaminergic neurotransmission, 
predisposing to depression[7 -9]. Depression in 
patients with PD should thus be treated as a 
single entity. 
Depression is often overlooked by physicians 
because of the many shared clinical features 
between the two disorders, such as weight loss, 
sleep disturbance, fatigue, sexual dysfunction, 
forgetfulness, and bradykinesia. If the 
physician brings up the topic by asking specific 
depression-related questions, most patients 
will be honest and will discuss their mental 
state, although they often will not bring up 
"depression" themselves or identify the 
changes they are experiencing as depression 
[10]. 
Estimates of the incidence of comorbid 
depression vary widely, from 4% to 75%[11]. 
There are variations in incidence of depression 
in PD due to few epidemiological studies. The 
available surveys in research centres diagnose 
depression in 40% to 50% of patients with PD 
compared to community-based studies which 
have rates of depression that are less than 
10%[1]. Rates of depression in PD have also 
been shown to vary widely between different 
countries. Surveys in Norway[1] and 
China[12] found the rates of major depression 
were 7.5% and 16.5% respectively. 
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The Global Parkinson's Disease Survey, which 
included 1000 patients, 200 clinicians, and 187 
caregivers in five countries including the US, 
found that approximately half of PD patients 
had depressive symptoms that significantly 
impacted their daily functioning [13]. The fact 
that no Mrican country was included in this 
study lends credence to the assertion that the 
exact frequency and pattern of depression 
among Mricans has not been fully studied 
particularly in Mrica. 
It is known that in comparison to the general 
population, there is a considerable enhanced 
risk of depression in Parkinson's disease thus 
requiring that the physician screen all PD 
patients for depression [14].Additionally, 
depression can impair both fine motor skills 
and cognitive function and is a primary factor 
negatively affecting HRQOL in PD [14]. 
Using the Beck Depression Inventory II (BDI-
11)[15] as a psychometric measure of 
depression, this study set out to determine the 
frequency and severity of depression among 
Nigerians with PD presenting at the 
University of Port Harcourt Teaching 
Hospital. It will also relate the frequency and 
severity of depression to the stage and severity 
ofPD. We hope that results from this study will 
serve as a basis for comparison with studies 
among PD patients from other population and 
help fill the void created by a dearth in 
literature of studies on depression among 
Parkinson' disease patients in settings similar 
to ours. We however hypothesized that 
patients with PD would be depressed 
compared to the control group and the severity 
of depression will be worse in more advanced 
PD 
METHODS 
This cross sectional case-control study was 
conducted at the Neurology Out-patient Clinic 
of the University of Port Harcourt Teaching 
Hospital (UPTH), Port Harcourt, over a period 
of6 months (June-November 2009). 
Subjects were recruited using convenience 
sampling technique. The diagnosis of PD was 
based on the United Kingdom (UK) Parkinson 
's Disease Society Brain Bank Clinical 
Diagnostic Criteria [16, 17]. 
For every patient, we looked for a control with 
same gender and age +1- 2years. They 
comprised healthy volunteers without 
Parkinsonism or significant co-morbidities 
e.g. hypertension, diabetes mellitus, etc. based 
on their historical account and physical 
examination. 
Ethical approval to undertake the study was 
obtained from the UPTH Ethics Committee. 
Informed written consent was obtained from 
all recruited subjects. 
Sample size estimation 
The minimum sample size of patients required 
for the study was 28, calculated based on the 
method of Kish [18]. The standard normal 
deviation (z) was set at 1.96, which correspond 
to the 95%confidence interval. The proportion 
of patients with PD (p) was estimated at 59 per 
100,000[19], while the absolute deviation from 
p% that will be tolerated (d) was set at 0.009) 
The Beck Depression lnventory 1151 
The Beck Depression Inventory (BDI-11), is a 
21-question multiple-choice self-report 
inventory, one of the most widely used 
instruments for measuring the severity of 
depression and the standard by which other 
depression measures are evaluated[20,21]. It 
has also been widely used and validated in 
Nigeria [22, 23]. Its validity and retest 
reliability in Parkinson's disease has been 
previously demonstrated [24, 25]. This 
instrument is more strongly weighted to 
assess cognitive symptoms of depression (e.g. 
guilt, loss of pleasure), although it has a 
number of questions that focus on somatic 
symptoms. A cluster analysis has shown that 
the BDI is a valid instrument for quantifying 
depression in PD patients [26].The 21-Item 
BDI-11 scale contains 13 items comprising the 
BDI Cognitive-Affective Subscale which 
evaluates sadness, pessimism, guilt feeling, 
irritability, suicidal thoughts and other 
affective and cognitive symptoms of 
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depression. The other 8 items that assess sleep 
disturbance, loss of appetite, fatigue, work 
difficulty and other somatic and performance 
decrement make up the BDI Somatic-
Performance Subscale [21]. 
TEST PROCEDURE 
Thirty-six consecutive patients who met the 
inclusion criteria and gave consent as well as 
thirty six age and sex matched controls were 
clinically assessed using standardized 
questionnaires administered by one of the 
authors (OOC) to obtain demographic 
information including occupation, marital 
status, primary language used, medical 
history, previous psychiatric history, alcohol 
history and history of use of drugs of abuse. 
The questionnaire also assessed disease-
related variables such as age at onset, 
duration of disease, duration of treatment, 
profile of motor and non-motor features of PD. 
The ease of use of the questionnaire/ proforma 
for data collection had been pretested in a pilot 
study using 10 patients and 10 matched 
controls that satisfied the recruitment 
criteria. The pilot study was also used to 
pretest the instrument and proforma before 
the main study. 
On the same day of the clinic visit neurological 
examination was performed on the patients by 
a Neurologist (OOC or AGE) to verify the 
clinical diagnosis of PD. Subsequently,the 
stage and severity of the disease was 
determined by using the Hoehn and Yahr 
staging scale [27] and the motor part of the 
Unified Parkinson's Disease Rating Scale 
(UPDRS) [28]. Thereafter, all recruited 
participants were instructed to respond to the 
BDI items by choosing one of four statements 
of varying severity that 'best described the way 
they had been feeling in the past two weeks 
including the day of testing. Each item was 
scored on a four point rating scale with value 
ranging from O(N o depression) to 3(maximum 
depression).All questionnaires were 
administered by the authors in English 
language as all eligible subjects spoke and 
understood English. 
Data Analysis 
Summary scores as well as the sub dimensions 
ofBDI were calculated according to its scoring 
algorithm. Data was analyzed using the SPSS 
version 15.0The BDI scores were summarized 
using means, median and standard deviation. 
The difference in mean scores between the 
sample of patients with Parkinson's disease 
and the reference population were tested 
using the Students t-test. A p-value of 0.05 or 
less was considered statistically significant. 
The association between pattern of scores on 
subunits of the BDI-11 scale and the stage and 
severity ofPD were analysed using t-test and 
AN OVA/linear regression. 
RESULTS 
Demographic characteristics 
The sample consisted of 36 patients with 
Parkinson's disease (PD) and 36 healthy 
controls, comprising 27(75%) men and 9(25%) 
women in the PD group while the control group 
consisted of 28(77.8%) men and 8(22.2%) 
women. The mean age of the patients with PD 
was 64.3 ± 10.9 years and 63.7 ± 9.2years for 
the controls with no significant difference in 
gender (p = 0.83). 
More than half of both groups were married 
(77.8% and 83.3% respectively).Fifteen 
(41.7%) PD patients as against 24 (66.7%) 
controls were in paid employment. More than 
half of the PD patients-21 (58.3%) were 
retirees. All of the recruited patients and 
control had no history of previous psychiatric 
illness or history of consumption of significant 
quantity of alcohol or of drug of abuse. All 
patients and controls outside their primary 
native tongues spoke and understood English 
language. 
Clinical characteristics 
Distribution of clinical features among PD 
patients: Majority of the respondents had 
motor features. All (100%) had bradykinesia, 
34(94.4 %) had tremors while gait 
abnormalities and imbalance were found in 
32(88.9%). Non-motor features most 
commonly found included persistently low 
mood in 30(83.3%), pain in 27(75%), olfactory 
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problems in 27 (75%), and difficulty 
remembering events in 17(47.2%) and 
drooling of saliva in 17(47.2%) as shown in 
Tables 1&2. 
BDI scores of PD patients compared with 
Healthy Controls 
The mean BDI score for PD patients was 23.6 ± 
6.4 with scores ranging from 7 to 36, while that 
for the controls was 6.2± 2.4, with a range of 
scores from 0 to 12. There were significant 
differences in the mean scores ofBDI between 
the PD patients and the controls. (p5. 0.001) 
Frequency ofDepression among PD patients 
Using the cut-off scores empirically 
established by Kendall et al (1987)[29], only 
one patient (2. 7%) had a BDI score in the 
range typically considered as non-depressed 
(0-9), 5.6% in the range considered dysphonic 
(10-15), and 91.7% in the range frequently 
labeled as depressed (~16),(Table 3). 
Table 4 shows means and standard deviations 
for each BDI item as well as the prevalence 
with which each BDI item was positively 
endorsed (i.e., a non-zero response). Mean 
ratings for individual items ranged from a low 
of0.08 for Item 9 (Suicidal ideation) to a high of 
1.86 for Item 20 (Somatic concern). The most 
frequently endorsed items were depressed 
mood, decreased initiative, anhedonia and loss 
of appetite. 
Depression and Parkinson disease severity 
The BDI scores of PD patients was positively 
correlated with the UPDRS score (r= 0.539 p = 
0.001). The mean BDI scores of the 29(79.6%) 
PD patients with Hoehn and Yahr stage 1-3 
(classified as moderate PD disease) was 
22.45± 6.37 while the mean BDI score of the 
remaining 7(19.4%) patients with Hoehn and 
Yahr between stage 4 and 5 (classified as 
severe PD disease) was 28.43± 4.83. This 
difference in means was statistically 
significant (t = 2.32 p= 0.027). 
There was however no statistically significant 
difference between class of depression and 
Hoehn and Yahr stage of Parkinsonism on chi 
square test (see table 5). 
Table 1: Frequency of motor features among 




















Table 2: Frequency of non-motor features among 
Parkinson's disease patients. 
Non motor feature 








Olfactory problems 27 75.00 
Difficulty remembering event [ 7 4 7.20 
Drooling saliva 17 4 7.20 
Difficulty falling asleep 12 33.30 







Table 3: Severity of depression using the 
Beck's Depression Inventory (BDI-11) 
Noof Noof t p 
Classification BDI score Patients (%) controls value 
(%) 
Non ~epresse~ ij.~ 
Dysphocic W-1n 
Mil~ ~epression 1~-~ij 
Mo~erate ~epression ~1-~ij 
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Table 4: Means, standard deviations, and 
prevalence of the 21 items on the BDI 
BDIITEM 
!.Depressed mood 
2.Pessimism regarding future 
3.Sense of failure 
4.Anhedonia 
5.Guilty feelings 






12. Social withdrawal 
13.Difficulty making decisions 
14. Distorted body image 
15. Decreased initiative 
16. Sleep disturbance 
17. Anergialfatigue 
18. Loss of appetite 
19. Weight loss 
20. Somatic concerns 













































Table 5: Association between BDI classification 
of depression and stage of Parkinsonism 
BDI Classification H andY stage r p value 
2and3 4and5 6.56 0.161 
Non depressed 1 0 
Dysphonic 2 0 
Mild depression 0 9 
Moderate depression 4 14 
Severe depression 3 3 
DISCUSSION 
The frequency of depression among PD 
patients in this study was very high and 
significant correlation was found between 
depression and disease severity. Most 
Parkinson's disease patients had some form of 
depression while about half of the population 
had moderate depression. Estimations of 
occurrence of depression in patients with 
Parkinson's disease vary from 20%-90% 
according to disease severity and the 
diagnostic criteria used [30]. A recent study by 
Ojo et al, reported a high frequency of 
depression of 55% among forty Parkinson's 
disease patients in a study in Lagos, Nigeria. 
This study used the Zung Self Rating 
Depression Scale [31]. We used the Beck's 
depression inventory and our overall 
frequency of 91.7% (mild, moderate and 
severe) was higher than those from previous 
studies [30-33]. One reason for this could be 
that the population for this study was a 
tertiary care setting. Some investigators have 
argued that patients with Parkinson's disease 
in hospital settings are more likely to 
experience depression than patients with 
Parkinson's disease who live in the community 
[1]. Tandberg et al [1], found a lower 
prevalence rate of 7. 7% for major depression 
using DSM-III criteria, MADRS and BDI 
scores in a community-based study. While 45% 
of the patients with Parkinson's disease were 
found to have mild depression as determined 
by the MADRS, only 5.1% of these patients 
were moderately or severely depressed [1]. 
Our Parkinson's disease patients however 
showed varied features of depression. The key 
feature of depression is anhedonia, which is 
defined as low and an impaired interest or 
ability to experience pleasure[34]. Our study 
substantiated this as more than half of the PD 
patients endorsed anhedonia in the BDI-11. It 
is good to say here that the profile of depressive 
symptoms observed in PD is not identical to 
that reported in patients with idiopathic 
depression[35]. In this study, we found really 
elevated levels of decreased initiative, 
depressed mood (sadness), anhedonia and loss 
of appetite. We also found high levels of sleep 
disturbance, loss of libido and pessimism 
regarding the future but little guilt, self-
dislike, sense of failure and very little suicidal 
ideation. This is similar to the findings of 
Brown et al [36]who analysed the Beck 
Depression Inventory scores of 132 patients 
with PD and found elevated levels of 
dysphonia and pessimism about the future, 
irritability, sadness, and suicidal ideation but 
The Nigerian Health Journal, Vol. 13, No 2, April -June, 2013 I Page l[.j.J 
Depression among Patient with Parkinson's Disease- Okunoye O.C. Asekomeh G. E. 
little guilt, self-blame, or feelings of failure or 
punishment. There is however a low suicide 
rate despite a high frequency of suicidal 
ideation among patients with PD. This pattern 
of sadness without guilt or self-reproach has 
been confirmed by several investigators [37-
40] 
The major difference in our study was the very 
little suicidal ideation which was the least 
item endorsed. This difference may not be 
unrelated to a difference in cultural 
background. In Nigeria like in most other 
Mrican countries, most cultures consider 
suicide a taboo. One other explanation could be 
the availability of family support from the 
extended family system that is in operation in 
Mrica. This often mitigates the impact of 
chronic illnesses on the quality of life of the 
patient. 
Other distinctive features of depression in PD 
include a high rate of anxiety symptoms,and a 
relative lack of delusions and hallucinations[7, 
32,41]. 
These observations indicate that depression in 
PD is subtly different from idiopathic mood 
disorders and raises the intriguing possibility 
that there may be disease-specific depression 
syndromes with distinctive mood profiles in 
different conditions. Also in our study, we 
discovered that depression was worse with 
severity of Parkinson's disease though 
depression in Parkinson's disease does not 
consistently correlate with severity of motor 
symptoms or functional disability [ 42- 44]. 
A major limitation of this study is the 
relatively small sample size of recruited 
patients. This is however a reflection of the 
rarity of Parkinson's disease. Nonetheless, 
this study is likely to provide a good 
representation of clinical practice, in which 
patients with Parkinson's disease are 
commonly assessed for depression and 
treatment instituted early enough to improve 
their quality of life. Future studies should 
employ the DSM-IV criteria and other 
depression scales for comparison. 
We therefore conclude that depression is 
common among patients with Parkinson's 
disease presenting at the University of Port 
Harcourt Teaching Hospital. This may also be 
the case in settings similar to ours in other 
parts of the Nigeria and sub-Saharan Mrica. 
Treating depression may improve the patient's 
quality of life. Physicians need to routinely 
evaluate patients for presence of depression 
during clinical evaluations. 
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